Meta Health Limited
Meta Health Limited
Meta Health Limited (META), formerly known as Metal Component Engineering Limited, was founded in 1987 in Singapore. With consistent focus on quality and engineering innovation, META has expanded its customer base by serving MNC (Multi-National-Corporation), EMS (Electronic Manufacturing Services), and SME (Small-Medium-Enterprise) globally.
META has recently diversified into healthcare technology and services with investment into Gainhealth Pte. Ltd., a direct-to-consumer and high-growth omnichannel health and wellness platform. Their healthcare segments now include (1) Primary & Homecare, (2) Central Pharmacy, (3) Clinical Nutrition distribution and (4) Infrastructure as a service (where they help medical institutes digitalise their operations)
1HFY2022 Results Announcement
15 Aug 2022
- 18 June 2o22
Financial Statements and Related Announcement::Profit Guidance - 12 May 2o22
Asset Acquisitions and Disposals::PROPOSED ACQUISITION OF REMAINING SHARES IN GAINHEALTH PTE. LTD. - Response to SGX Queries::
- 24 May 2o22
General Announcement::CHANGES IN COMPOSITION OF THE BOARD AND THE BOARD COMMITTEES - 24 June 2o22
Change – Announcement of Appointment::Appointment of Independent Non-Executive Director – Mr Law Ren Kai Kenneth - 17 June 2o22
Change – Announcement of Cessation::Cessation of Independent Non-Executive Director – MChange – Announcement of Cessation::Resignation of Chief Financial Officer and Joint Company Secretarys Leow Siew Yon, Cynthia
- 06 June 2o22
General Announcement::PRESS RELEASE – META HEALTH LIMITED APPOINTS DR BERNARD NG AS CHAIRMAN OF THE BOARD AND GROUP CEO - 11 May 2o22
ACQUISITION OF GAINHEALTH PTE. LTD. – PAYMENT OF ACTUAL PERFORMANCE BONUS - 6 Apr 2o22
Meta Health supports the development of Bali as a medical travel hub within Indonesia - 1 Mar 2o22
Financial Statements and Related Announcement::Full Yearly Results - 9 Feb 2o22
1 Mar 2o22 Financial Statements and Related Announcement::Full Yearly Results
-
0.9x P/B with a strong net cash position
-
Proxy to the digitalization of healthcare in the region
-
Infrastructure-as-a-service (IAAS) segment, a potential crown jewel, that can be highly scalable and profitable.
-
Clinical Nutrition Distribution, a highly complementary segment as it taps on central pharmacy’s B2B network for distribution
| Price | 0.0390 |
|---|---|
| Market Cap (SGDm) | 20.5M |
| YE | 31 Dec 21 |
| Free Float % | 97.2% |
| Key Highlights | 2020 | 2021 |
|---|---|---|
| Revenue (SGD m) | 32.2 | 43.0 |
| Net Profit | (2.0) | 7.6 |
| Adjusted net Profit/(Loss) to Owners | (2.o) | (1.6)* |
| Net Asset Value | 15.3 | 23.0 |
| Net Cash/(Debt) | (1.5) | 4.7 |